Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY2963016 vs Lantus in adult type 1 diabetes in China
CTR20171056Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin glargine in diabetes mellitus type 1 (T1D), sponsored by Eli Lilly and Company. Started Mar 2018; status: completed.
02
Drugs
insulin glargine
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on CTR20171056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171056.